Taperloc Complete Micro Primary Femoral 51-106180Recalls & reported problems
Biomet Orthopedics, LLC · Class 2 · Implant
All models of Taperloc Complete Micro Primary Femoral (35)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00880304514447), received between Nov 21, 2022 and Nov 19, 2025 — classified as 2 injuries, 5 malfunctions.
The most frequently reported specific device problem is “Delivered as Unsterile Product” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Delivered as Unsterile Product2
- Manufacturing, Packaging or Shipping Problem2
- Adverse Event Without Identified Device or Use Problem1
- Failure to Osseointegrate1
- Positioning Problem1
- Tear, Rip or Hole in Device Packaging1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- Ambulation or Postural Difficulties1
- Failure of Implant1
- Inadequate Osseointegration1
- Pain1
- Periprosthetic fracture1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryNov 19, 2025Adverse Event Without Identified Device or Use Problem; Positioning Problem; Adverse Event Without Identified Device or Use Problem; Positioning Problem
IT WAS REPORTED THAT FOLLOWING AN ARTHROPLASTY, THE PATIENT SUSTAINED A FEMORAL BONE FRACTURE AND WAS BEING CONSIDERED FOR REVISION. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.
Patient problems: Failure of Implant; Periprosthetic fracture
MAUDE report 23593864 ↗MalfunctionAug 11, 2025Manufacturing, Packaging or Shipping Problem; Manufacturing, Packaging or Shipping Problem
IT WAS REPORTED THAT DEBRIS WAS FOUND IN THE STERILE PACKAGING. THERE WAS NO KNOWN IMPACT OR CONSEQUENCES TO THE PATIENT. THE SURGEON USED ANOTHER DEVICE TO COMPLETE THE PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22769966 ↗MalfunctionAug 27, 2024Delivered as Unsterile Product; Delivered as Unsterile Product
IT WAS REPORTED THAT STEM HAD A HOLE IN THE PACKAGING. ANOTHER STEM WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO KNOWN IMPACT OR CONSEQUENCES TO THE PATIENT. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20076832 ↗MalfunctionJun 17, 2024Delivered as Unsterile Product; Delivered as Unsterile Product
IT WAS REPORTED THAT DURING SURGERY, THE SURGEON PREPPED THE FEMUR AND DETERMINED A SIZE 18 STEM WOULD FIT. THE SEALED BOX FOR THE STEM WAS OPENED AND THE HARD PLASTIC PACKAGING HAD A HOLE IN THE CORNER. THE IMPLANT WAS DEEMED NOT STERILE AND THE FEMUR CANAL WAS RE-PREPPED FOR A SIZE 17 STEM. THERE WAS NO KNOWN IMPACT OR CONSEQUENCES TO THE PATIENT. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19546825 ↗MalfunctionOct 2, 2023Manufacturing, Packaging or Shipping Problem; Manufacturing, Packaging or Shipping Problem
NO FURTHER INFORMATION IS AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17852566 ↗MalfunctionMay 22, 2023Tear, Rip or Hole in Device Packaging; Tear, Rip or Hole in Device Packaging
THERE IS NO UPDATE TO THE PRIOR EVENT DESCRIPTION PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16976902 ↗InjuryNov 21, 2022Failure to Osseointegrate; Failure to Osseointegrate
IT WAS REPORTED THAT THE PATIENT HAD A LEFT HIP REVISION APPROXIMATELY 10 MONTHS POST INITIAL IMPLANTATION AND SUBSEQUENTLY HAD TO HAVE A SECOND REVISION DUE TO PAIN AND LOOSENING OF THE FEMORAL STEM APPROXIMATELY 7 MONTHS LATER. THE HEAD AND THE STEM WERE REPLACED WITHOUT COMPLICATION. THERE IS NO ADDITIONAL INFORMATION PROVIDED AT THE TIME OF THIS REPORT.
Patient problems: Ambulation or Postural Difficulties; Inadequate Osseointegration; Pain
MAUDE report 15832947 ↗
Other PROSTHESIS, TOE, CONSTRAINED, POLYMER devices
- Taperloc Complete Micro Primary Femoral 51-109070Biomet Orthopedics, LLC · PROSTHESIS, TOE, CONSTRAINED, POLYMER24 reports
- Taperloc Complete Micro Primary Femoral 51-106100Biomet Orthopedics, LLC · PROSTHESIS, TOE, CONSTRAINED, POLYMER13 reports
- Taperloc Complete Micro Primary Femoral 51-109080Biomet Orthopedics, LLC · PROSTHESIS, TOE, CONSTRAINED, POLYMER9 reports
- Taperloc Complete Micro Primary Femoral 51-108070Biomet Orthopedics, LLC · PROSTHESIS, TOE, CONSTRAINED, POLYMER6 reports
- Taperloc Complete Micro Primary Femoral 51-106120Biomet Orthopedics, LLC · PROSTHESIS, TOE, CONSTRAINED, POLYMER4 reports
- RTS M40 SE020In2Bones USA, LLC · Prosthesis, Toe, Constrained, Polymer3 reports
- SWANSON G4260102Wright Medical Technology, Inc. · PROSTHESIS, TOE, CONSTRAINED, POLYMER2 reports
- RTS M40 SE030In2Bones USA, LLC · Prosthesis, Toe, Constrained, Polymer1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page